Mounjaro KwikPen 10 mg
  1. Home
  2. Mounjaro
  3. Mounjaro KwikPen 10 mg

Mounjaro KwikPen 10 mg

Mounjaro KwikPen 10 mg is a prescription dual GIP and GLP-1 receptor agonist prefilled multi-dose injection pen used to improve glycemic control in adults with type 2 diabetes when combined with diet and exercise. It delivers 10 mg of tirzepatide by once-weekly subcutaneous injection and is commonly prescribed as part of the maintenance treatment regimen. The KwikPen provides convenient, accurate, and reliable dose administration.

BUY NOW

Category

Mounjaro KwikPen 10 mg contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps improve blood glucose control by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The 10 mg strength is typically prescribed after gradual dose escalation to achieve sustained glycemic control and support long-term metabolic management when clinically appropriate. Manufactured under stringent pharmaceutical quality standards, the sterile multi-dose KwikPen is engineered for precise subcutaneous administration and dependable clinical performance. Mounjaro KwikPen 10 mg should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro KwikPen 10 mg
Active Ingredient Tirzepatide
Strength 10 mg
Dosage Form Multi-dose Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Mounjaro KwikPen 10 mg, Tirzepatide 10 mg KwikPen, Mounjaro 10 mg Pen, Tirzepatide Injection Pen, GIP GLP-1 Injection Pen, Weekly Tirzepatide Pen, Multi-dose Tirzepatide Pen